Mark Mirken - Cannlabs Chairman, CEO and Member of Audit Committee
| CANL Stock | USD 0.0001 0.00 0.00% |
Chairman
Mr. Mark C. Mirken is Chairman of the Board, Chief Executive Officer of Company. He was Vice Chairman of the Board of the Company. He was Chief Executive Officer of the Company. Mr. Mirken is the former Chief Executive Officer of Millennium BiotechnologiesInergetics where he served from 2005 to 2012. Inergetics is a leading developer of advanced proprietary nutritional products that improve overall health, physical recovery, athletic performance and quality of life for patients and consumers. Mr. Mirken joined TurboChef Technologies, Inc. in 2000 to lead the global sales division that took the company to be a world leader in technology, equipment and services for highspeed food preparation. He then went on to serve the company as President and Chief Operating Officer from 2002 to 2005. Subsequent to 2012 and prior to joining CannLabs, Mr. Mirken was performing management consulting services. In 2013, Mr. Mirken filed a petition under Chapter 11 of the United States Bankruptcy Code. Mr. Mirken has over 25 years of senior management experience that has allowed him to lead companies through startup, growth, capital restructuring, capital raising and branding initiatives. since 2015.
| Age | 78 |
| Tenure | 10 years |
| Phone | 303-309-0105 |
| Web | http://www.cannlabs.com |
Cannlabs Management Efficiency
The company has return on total asset (ROA) of (3.6216) % which means that it has lost $3.6216 on every $100 spent on assets. This is way below average. Cannlabs' management efficiency ratios could be used to measure how well Cannlabs manages its routine affairs as well as how well it operates its assets and liabilities. CannLabs, Inc. provides cannabis testing laboratory services in the United States. The company also offers dataanalytics and consulting, as well as education services. Cannlabs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 37 people. Cannlabs [CANL] is a Pink Sheet which is traded between brokers over the counter.Management Performance
| Return On Asset | -3.62 |
Cannlabs Leadership Team
Elected by the shareholders, the Cannlabs' board of directors comprises two types of representatives: Cannlabs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cannlabs. The board's role is to monitor Cannlabs' management team and ensure that shareholders' interests are well served. Cannlabs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cannlabs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Wempe, Head of Consulting and Research Department | ||
| Mark Mirken, Chairman, CEO and Member of Audit Committee |
Cannlabs Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Cannlabs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -3.62 | |||
| Profit Margin | (0.96) % | |||
| Operating Margin | (2.50) % | |||
| Current Valuation | 14.91 M | |||
| Shares Outstanding | 62.63 M | |||
| Price To Earning | (4.81) X | |||
| Price To Book | 25.41 X | |||
| Price To Sales | 6.91 X | |||
| Revenue | 1.36 M | |||
| Gross Profit | 478.11 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Cannlabs Pink Sheet
Cannlabs financial ratios help investors to determine whether Cannlabs Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannlabs with respect to the benefits of owning Cannlabs security.